Literature DB >> 15309696

Early and subtle abnormalities of left ventricular function in clinically stable coronary artery disease patients with normal ejection fraction.

R Bolognesi1, D Tsialtas, R Zeppellini, A L Barilli, F Cucchini, C Manca.   

Abstract

BACKGROUND: It has been reported that, in the initial phase of ischemic cardiomyopathy, the earliest alterations of left ventricular function are detected during the relaxation phase. The aim of this study was to look for precocious abnormalities in the early stage of ischemic cardiomyopathy in both left ventricular systolic and diastolic phases. METHODS AND
RESULTS: Using simultaneous left ventricular catheterization and echo-Doppler techniques, we studied both systolic and diastolic function in 44 (37 males and 7 females, mean age 55.7+/-8) normotensive, clinically stable, coronary artery disease patients with normal left ventricular ejection fraction in comparison to 9 age- and sex-matched normal control subjects (7 males and 2 females, mean age 54.7+/-9). Mean values of E deceleration time, tau, left ventricular end-diastolic volume and pressure, and end-systolic volume and lowest diastolic pressure were significantly higher (from P<.05 to P<.01), whereas mean dP/dt/P values significantly lower (P<.05) in coronary artery disease patients than in controls. A strict relationship (P<.001) between dP/dt/P and tau, left ventricular lowest and end-diastolic pressure was found in all subjects studied.
CONCLUSION: Early and subtle abnormalities in parameters of both systolic and diastolic function can be found in the majority of coronary artery disease patients with normal ejection fraction.

Entities:  

Mesh:

Year:  2004        PMID: 15309696     DOI: 10.1016/j.cardfail.2003.10.010

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  2 in total

1.  Assessing left ventricular systolic dysfunction after myocardial infarction: are ejection fraction and dP/dt(max) complementary or redundant?

Authors:  Kiyotake Ishikawa; Elie R Chemaly; Lisa Tilemann; Kenneth Fish; Dennis Ladage; Jaime Aguero; Torsten Vahl; Carlos Santos-Gallego; Yoshiaki Kawase; Roger J Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-03       Impact factor: 4.733

2.  Diacerein improves left ventricular remodeling and cardiac function by reducing the inflammatory response after myocardial infarction.

Authors:  Anali Galluce Torina; Karla Reichert; Fany Lima; Karlos Alexandre de Souza Vilarinho; Pedro Paulo Martins de Oliveira; Helison Rafael Pereira do Carmo; Daniela Diógenes de Carvalho; Mário José Abdalla Saad; Andrei Carvalho Sposito; Orlando Petrucci
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.